<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;ff=20240317001020&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_source=Chrome&amp;ff=20240317001020&amp;utm_medium=rss&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sun, 17 Mar 2024 04:10:21 +0000</lastbuilddate>
<pubDate>Sat, 16 Mar 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Imaging cAMP nanodomains in human iPSC-derived cardiomyocytes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38491187/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Mar 15. doi: 10.1038/s41569-024-01013-1. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38491187/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38491187</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01013-1>10.1038/s41569-024-01013-1</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38491187</guid>
<pubDate>Sat, 16 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Camille Charrière</dc:creator>
<dc:date>2024-03-16</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Imaging cAMP nanodomains in human iPSC-derived cardiomyocytes</dc:title>
<dc:identifier>pmid:38491187</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01013-1</dc:identifier>
</item>
<item>
<title>Type-I-interferon-responsive microglia shape cortical development and behavior</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490196/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Microglia are brain-resident macrophages that shape neural circuit development and are implicated in neurodevelopmental diseases. Multiple microglial transcriptional states have been defined, but their functional significance is unclear. Here, we identify a type I interferon (IFN-I)-responsive microglial state in the developing somatosensory cortex (postnatal day 5) that is actively engulfing whole neurons. This population expands during cortical remodeling induced by partial whisker...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 8:S0092-8674(24)00186-7. doi: 10.1016/j.cell.2024.02.020. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Microglia are brain-resident macrophages that shape neural circuit development and are implicated in neurodevelopmental diseases. Multiple microglial transcriptional states have been defined, but their functional significance is unclear. Here, we identify a type I interferon (IFN-I)-responsive microglial state in the developing somatosensory cortex (postnatal day 5) that is actively engulfing whole neurons. This population expands during cortical remodeling induced by partial whisker deprivation. Global or microglial-specific loss of the IFN-I receptor resulted in microglia with phagolysosomal dysfunction and an accumulation of neurons with nuclear DNA damage. IFN-I gain of function increased neuronal engulfment by microglia in both mouse and zebrafish and restricted the accumulation of DNA-damaged neurons. Finally, IFN-I deficiency resulted in excess cortical excitatory neurons and tactile hypersensitivity. These data define a role for neuron-engulfing microglia during a critical window of brain development and reveal homeostatic functions of a canonical antiviral signaling pathway in the brain.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490196/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490196</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.020>10.1016/j.cell.2024.02.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490196</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Caroline C Escoubas</dc:creator>
<dc:creator>Leah C Dorman</dc:creator>
<dc:creator>Phi T Nguyen</dc:creator>
<dc:creator>Christian Lagares-Linares</dc:creator>
<dc:creator>Haruna Nakajo</dc:creator>
<dc:creator>Sarah R Anderson</dc:creator>
<dc:creator>Jerika J Barron</dc:creator>
<dc:creator>Sarah D Wade</dc:creator>
<dc:creator>Beatriz Cuevas</dc:creator>
<dc:creator>Ilia D Vainchtein</dc:creator>
<dc:creator>Nicholas J Silva</dc:creator>
<dc:creator>Ricardo Guajardo</dc:creator>
<dc:creator>Yinghong Xiao</dc:creator>
<dc:creator>Peter V Lidsky</dc:creator>
<dc:creator>Ellen Y Wang</dc:creator>
<dc:creator>Brianna M Rivera</dc:creator>
<dc:creator>Sunrae E Taloma</dc:creator>
<dc:creator>Dong Kyu Kim</dc:creator>
<dc:creator>Elizaveta Kaminskaya</dc:creator>
<dc:creator>Hiromi Nakao-Inoue</dc:creator>
<dc:creator>Bjoern Schwer</dc:creator>
<dc:creator>Thomas D Arnold</dc:creator>
<dc:creator>Ari B Molofsky</dc:creator>
<dc:creator>Carlo Condello</dc:creator>
<dc:creator>Raul Andino</dc:creator>
<dc:creator>Tomasz J Nowakowski</dc:creator>
<dc:creator>Anna V Molofsky</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Type-I-interferon-responsive microglia shape cortical development and behavior</dc:title>
<dc:identifier>pmid:38490196</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.020</dc:identifier>
</item>
<item>
<title>Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490195/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>The immune checkpoint blockade (ICB) response in human cancers is closely linked to the gut microbiota. Here, we report that the abundance of commensal Lactobacillus johnsonii is positively correlated with the responsiveness of ICB. Supplementation with Lactobacillus johnsonii or tryptophan-derived metabolite indole-3-propionic acid (IPA) enhances the efficacy of CD8^(+) T cell-mediated αPD-1 immunotherapy. Mechanistically, Lactobacillus johnsonii collaborates with Clostridium sporogenes to...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 11:S0092-8674(24)00224-1. doi: 10.1016/j.cell.2024.02.022. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The immune checkpoint blockade (ICB) response in human cancers is closely linked to the gut microbiota. Here, we report that the abundance of commensal Lactobacillus johnsonii is positively correlated with the responsiveness of ICB. Supplementation with Lactobacillus johnsonii or tryptophan-derived metabolite indole-3-propionic acid (IPA) enhances the efficacy of CD8<sup>+</sup> T cell-mediated αPD-1 immunotherapy. Mechanistically, Lactobacillus johnsonii collaborates with Clostridium sporogenes to produce IPA. IPA modulates the stemness program of CD8<sup>+</sup> T cells and facilitates the generation of progenitor exhausted CD8<sup>+</sup> T cells (T<sub>pex</sub>) by increasing H3K27 acetylation at the super-enhancer region of Tcf7. IPA improves ICB responsiveness at the pan-cancer level, including melanoma, breast cancer, and colorectal cancer. Collectively, our findings identify a microbial metabolite-immune regulatory pathway and suggest a potential microbial-based adjuvant approach to improve the responsiveness of immunotherapy.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490195/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490195</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.022>10.1016/j.cell.2024.02.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490195</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Dingjiacheng Jia</dc:creator>
<dc:creator>Qiwen Wang</dc:creator>
<dc:creator>Yadong Qi</dc:creator>
<dc:creator>Yao Jiang</dc:creator>
<dc:creator>Jiamin He</dc:creator>
<dc:creator>Yifeng Lin</dc:creator>
<dc:creator>Yong Sun</dc:creator>
<dc:creator>Jilei Xu</dc:creator>
<dc:creator>Wenwen Chen</dc:creator>
<dc:creator>Lina Fan</dc:creator>
<dc:creator>Ruochen Yan</dc:creator>
<dc:creator>Wang Zhang</dc:creator>
<dc:creator>Guohong Ren</dc:creator>
<dc:creator>Chaochao Xu</dc:creator>
<dc:creator>Qiwei Ge</dc:creator>
<dc:creator>Lan Wang</dc:creator>
<dc:creator>Wei Liu</dc:creator>
<dc:creator>Fei Xu</dc:creator>
<dc:creator>Pin Wu</dc:creator>
<dc:creator>Yuhao Wang</dc:creator>
<dc:creator>Shujie Chen</dc:creator>
<dc:creator>Liangjing Wang</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer</dc:title>
<dc:identifier>pmid:38490195</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.022</dc:identifier>
</item>
<item>
<title>First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490194/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Diminished hepatocyte regeneration is a key feature of acute and chronic liver diseases and after extended liver resections, resulting in the inability to maintain or restore a sufficient functional liver mass. Therapies to restore hepatocyte regeneration are lacking, making liver transplantation the only curative option for end-stage liver disease. Here, we report on the structure-based development and characterization (nuclear magnetic resonance [NMR] spectroscopy) of first-in-class small...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 8:S0092-8674(24)00225-3. doi: 10.1016/j.cell.2024.02.023. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Diminished hepatocyte regeneration is a key feature of acute and chronic liver diseases and after extended liver resections, resulting in the inability to maintain or restore a sufficient functional liver mass. Therapies to restore hepatocyte regeneration are lacking, making liver transplantation the only curative option for end-stage liver disease. Here, we report on the structure-based development and characterization (nuclear magnetic resonance [NMR] spectroscopy) of first-in-class small molecule inhibitors of the dual-specificity kinase MKK4 (MKK4i). MKK4i increased liver regeneration upon hepatectomy in murine and porcine models, allowed for survival of pigs in a lethal 85% hepatectomy model, and showed antisteatotic and antifibrotic effects in liver disease mouse models. A first-in-human phase I trial (European Union Drug Regulating Authorities Clinical Trials [EudraCT] 2021-000193-28) with the clinical candidate HRX215 was conducted and revealed excellent safety and pharmacokinetics. Clinical trials to probe HRX215 for prevention/treatment of liver failure after extensive oncological liver resections or after transplantation of small grafts are warranted.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490194/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490194</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.023>10.1016/j.cell.2024.02.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490194</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Stefan Zwirner</dc:creator>
<dc:creator>Anan A Abu Rmilah</dc:creator>
<dc:creator>Sabrina Klotz</dc:creator>
<dc:creator>Bent Pfaffenroth</dc:creator>
<dc:creator>Philip Kloevekorn</dc:creator>
<dc:creator>Athina A Moschopoulou</dc:creator>
<dc:creator>Svenja Schuette</dc:creator>
<dc:creator>Mathias Haag</dc:creator>
<dc:creator>Roland Selig</dc:creator>
<dc:creator>Kewei Li</dc:creator>
<dc:creator>Wei Zhou</dc:creator>
<dc:creator>Erek Nelson</dc:creator>
<dc:creator>Antti Poso</dc:creator>
<dc:creator>Harvey Chen</dc:creator>
<dc:creator>Bruce Amiot</dc:creator>
<dc:creator>Yao Jia</dc:creator>
<dc:creator>Anna Minshew</dc:creator>
<dc:creator>Gregory Michalak</dc:creator>
<dc:creator>Wei Cui</dc:creator>
<dc:creator>Elke Rist</dc:creator>
<dc:creator>Thomas Longerich</dc:creator>
<dc:creator>Birgit Jung</dc:creator>
<dc:creator>Philipp Felgendreff</dc:creator>
<dc:creator>Omelyan Trompak</dc:creator>
<dc:creator>Prem K Premsrirut</dc:creator>
<dc:creator>Katharina Gries</dc:creator>
<dc:creator>Thomas E Muerdter</dc:creator>
<dc:creator>Georg Heinkele</dc:creator>
<dc:creator>Torsten Wuestefeld</dc:creator>
<dc:creator>David Shapiro</dc:creator>
<dc:creator>Markus Weissbach</dc:creator>
<dc:creator>Alfred Koenigsrainer</dc:creator>
<dc:creator>Bence Sipos</dc:creator>
<dc:creator>Eiso Ab</dc:creator>
<dc:creator>Magdalena Ortiz Zacarias</dc:creator>
<dc:creator>Stephan Theisgen</dc:creator>
<dc:creator>Nicole Gruenheit</dc:creator>
<dc:creator>Saskia Biskup</dc:creator>
<dc:creator>Matthias Schwab</dc:creator>
<dc:creator>Wolfgang Albrecht</dc:creator>
<dc:creator>Stefan Laufer</dc:creator>
<dc:creator>Scott Nyberg</dc:creator>
<dc:creator>Lars Zender</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure</dc:title>
<dc:identifier>pmid:38490194</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.023</dc:identifier>
</item>
<item>
<title>Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490183/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1565-1566. doi: 10.1016/j.cell.2024.02.015.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490183/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490183</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.015>10.1016/j.cell.2024.02.015</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490183</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Todd Logan</dc:creator>
<dc:creator>Matthew J Simon</dc:creator>
<dc:creator>Anil Rana</dc:creator>
<dc:creator>Gerald M Cherf</dc:creator>
<dc:creator>Ankita Srivastava</dc:creator>
<dc:creator>Sonnet S Davis</dc:creator>
<dc:creator>Ray Lieh Yoon Low</dc:creator>
<dc:creator>Chi-Lu Chiu</dc:creator>
<dc:creator>Meng Fang</dc:creator>
<dc:creator>Fen Huang</dc:creator>
<dc:creator>Akhil Bhalla</dc:creator>
<dc:creator>Ceyda Llapashtica</dc:creator>
<dc:creator>Rachel Prorok</dc:creator>
<dc:creator>Michelle E Pizzo</dc:creator>
<dc:creator>Meredith E K Calvert</dc:creator>
<dc:creator>Elizabeth W Sun</dc:creator>
<dc:creator>Jennifer Hsiao-Nakamoto</dc:creator>
<dc:creator>Yashas Rajendra</dc:creator>
<dc:creator>Katrina W Lexa</dc:creator>
<dc:creator>Devendra B Srivastava</dc:creator>
<dc:creator>Bettina van Lengerich</dc:creator>
<dc:creator>Junhua Wang</dc:creator>
<dc:creator>Yaneth Robles-Colmenares</dc:creator>
<dc:creator>Do Jin Kim</dc:creator>
<dc:creator>Joseph Duque</dc:creator>
<dc:creator>Melina Lenser</dc:creator>
<dc:creator>Timothy K Earr</dc:creator>
<dc:creator>Hoang Nguyen</dc:creator>
<dc:creator>Roni Chau</dc:creator>
<dc:creator>Buyankhishig Tsogtbaatar</dc:creator>
<dc:creator>Ritesh Ravi</dc:creator>
<dc:creator>Lukas L Skuja</dc:creator>
<dc:creator>Hilda Solanoy</dc:creator>
<dc:creator>Howard J Rosen</dc:creator>
<dc:creator>Bradley F Boeve</dc:creator>
<dc:creator>Adam L Boxer</dc:creator>
<dc:creator>Hilary W Heuer</dc:creator>
<dc:creator>Mark S Dennis</dc:creator>
<dc:creator>Mihalis S Kariolis</dc:creator>
<dc:creator>Kathryn M Monroe</dc:creator>
<dc:creator>Laralynne Przybyla</dc:creator>
<dc:creator>Pascal E Sanchez</dc:creator>
<dc:creator>Rene Meisner</dc:creator>
<dc:creator>Dolores Diaz</dc:creator>
<dc:creator>Kirk R Henne</dc:creator>
<dc:creator>Ryan J Watts</dc:creator>
<dc:creator>Anastasia G Henry</dc:creator>
<dc:creator>Kannan Gunasekaran</dc:creator>
<dc:creator>Giuseppe Astarita</dc:creator>
<dc:creator>Jung H Suh</dc:creator>
<dc:creator>Joseph W Lewcock</dc:creator>
<dc:creator>Sarah L DeVos</dc:creator>
<dc:creator>Gilbert Di Paolo</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic</dc:title>
<dc:identifier>pmid:38490183</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.015</dc:identifier>
</item>
<item>
<title>Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490182/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1563-1564. doi: 10.1016/j.cell.2024.02.007.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490182/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490182</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.007>10.1016/j.cell.2024.02.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490182</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Fa-Xing Yu</dc:creator>
<dc:creator>Bin Zhao</dc:creator>
<dc:creator>Nattapon Panupinthu</dc:creator>
<dc:creator>Jenna L Jewell</dc:creator>
<dc:creator>Ian Lian</dc:creator>
<dc:creator>Lloyd H Wang</dc:creator>
<dc:creator>Jiagang Zhao</dc:creator>
<dc:creator>Haixin Yuan</dc:creator>
<dc:creator>Karen Tumaneng</dc:creator>
<dc:creator>Hairi Li</dc:creator>
<dc:creator>Xiang-Dong Fu</dc:creator>
<dc:creator>Gordon B Mills</dc:creator>
<dc:creator>Kun-Liang Guan</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling</dc:title>
<dc:identifier>pmid:38490182</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.007</dc:identifier>
</item>
<item>
<title>ZP2 cleavage blocks polyspermy by modulating the architecture of the egg coat</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490181/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Following the fertilization of an egg by a single sperm, the egg coat or zona pellucida (ZP) hardens and polyspermy is irreversibly blocked. These events are associated with the cleavage of the N-terminal region (NTR) of glycoprotein ZP2, a major subunit of ZP filaments. ZP2 processing is thought to inactivate sperm binding to the ZP, but its molecular consequences and connection with ZP hardening are unknown. Biochemical and structural studies show that cleavage of ZP2 triggers its...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1440-1459.e24. doi: 10.1016/j.cell.2024.02.013.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Following the fertilization of an egg by a single sperm, the egg coat or zona pellucida (ZP) hardens and polyspermy is irreversibly blocked. These events are associated with the cleavage of the N-terminal region (NTR) of glycoprotein ZP2, a major subunit of ZP filaments. ZP2 processing is thought to inactivate sperm binding to the ZP, but its molecular consequences and connection with ZP hardening are unknown. Biochemical and structural studies show that cleavage of ZP2 triggers its oligomerization. Moreover, the structure of a native vertebrate egg coat filament, combined with AlphaFold predictions of human ZP polymers, reveals that two protofilaments consisting of type I (ZP3) and type II (ZP1/ZP2/ZP4) components interlock into a left-handed double helix from which the NTRs of type II subunits protrude. Together, these data suggest that oligomerization of cleaved ZP2 NTRs extensively cross-links ZP filaments, rigidifying the egg coat and making it physically impenetrable to sperm.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490181/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490181</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.013>10.1016/j.cell.2024.02.013</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490181</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Shunsuke Nishio</dc:creator>
<dc:creator>Chihiro Emori</dc:creator>
<dc:creator>Benjamin Wiseman</dc:creator>
<dc:creator>Dirk Fahrenkamp</dc:creator>
<dc:creator>Elisa Dioguardi</dc:creator>
<dc:creator>Sara Zamora-Caballero</dc:creator>
<dc:creator>Marcel Bokhove</dc:creator>
<dc:creator>Ling Han</dc:creator>
<dc:creator>Alena Stsiapanava</dc:creator>
<dc:creator>Blanca Algarra</dc:creator>
<dc:creator>Yonggang Lu</dc:creator>
<dc:creator>Mayo Kodani</dc:creator>
<dc:creator>Rachel E Bainbridge</dc:creator>
<dc:creator>Kayla M Komondor</dc:creator>
<dc:creator>Anne E Carlson</dc:creator>
<dc:creator>Michael Landreh</dc:creator>
<dc:creator>Daniele de Sanctis</dc:creator>
<dc:creator>Shigeki Yasumasu</dc:creator>
<dc:creator>Masahito Ikawa</dc:creator>
<dc:creator>Luca Jovine</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>ZP2 cleavage blocks polyspermy by modulating the architecture of the egg coat</dc:title>
<dc:identifier>pmid:38490181</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.013</dc:identifier>
</item>
<item>
<title>mRNA-based monkeypox virus vaccine prevents disease in non-human primates</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490180/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>The mpox outbreak in 2022 launched a vaccination campaign employing an existing vaccine with moderate protection, highlighting the lack of scalable Orthopoxvirus vaccines with optimal protection. In this issue of Cell, Zuiani et al. report pre-clinical findings of an mRNA-based mpox vaccine, paving the way for Phase I/II clinical trials.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1360-1362. doi: 10.1016/j.cell.2024.02.011.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The mpox outbreak in 2022 launched a vaccination campaign employing an existing vaccine with moderate protection, highlighting the lack of scalable Orthopoxvirus vaccines with optimal protection. In this issue of Cell, Zuiani et al. report pre-clinical findings of an mRNA-based mpox vaccine, paving the way for Phase I/II clinical trials.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490180/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490180</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.011>10.1016/j.cell.2024.02.011</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490180</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Adam N Nitido</dc:creator>
<dc:creator>Alejandro B Balazs</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>mRNA-based monkeypox virus vaccine prevents disease in non-human primates</dc:title>
<dc:identifier>pmid:38490180</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.011</dc:identifier>
</item>
<item>
<title>Judith Campisi (1948-2024)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490179/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1358-1359. doi: 10.1016/j.cell.2024.02.017.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490179/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490179</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.017>10.1016/j.cell.2024.02.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490179</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Eric Verdin</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Judith Campisi (1948-2024)</dc:title>
<dc:identifier>pmid:38490179</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.017</dc:identifier>
</item>
<item>
<title>The future of sex and gender in research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490178/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Our understanding of sex and gender evolves. We asked scientists about their work and the future of sex and gender research. They discuss, among other things, interdisciplinary collaboration, moving beyond binary conceptualizations, accounting for intersecting factors, reproductive strategies, expanding research on sex-related differences, and sex's dynamic nature.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1354-1357. doi: 10.1016/j.cell.2024.02.010.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Our understanding of sex and gender evolves. We asked scientists about their work and the future of sex and gender research. They discuss, among other things, interdisciplinary collaboration, moving beyond binary conceptualizations, accounting for intersecting factors, reproductive strategies, expanding research on sex-related differences, and sex's dynamic nature.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490178/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490178</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.010>10.1016/j.cell.2024.02.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490178</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Brian A Aguado</dc:creator>
<dc:creator>Daniel L Jeffries</dc:creator>
<dc:creator>Rebecca Jordan-Young</dc:creator>
<dc:creator>Sabra L Klein</dc:creator>
<dc:creator>Elle Lett</dc:creator>
<dc:creator>Nina Stachenfeld</dc:creator>
<dc:creator>Jessica Tollkuhn</dc:creator>
<dc:creator>Xiaohong Xu</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The future of sex and gender in research</dc:title>
<dc:identifier>pmid:38490178</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.010</dc:identifier>
</item>
<item>
<title>Shirin Heidari</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490177/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Dr. Shirin Heidari is the lead author of the Sex and Gender Equity in Research (SAGER) guidelines. In this interview with Dr. Isabel Goldman at Cell, she discusses her research, GENDRO, the SAGER guidelines and importance of considering sex- and gender-related variables in research, and her work on sexual and reproductive health in forced displacement.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1347-1349. doi: 10.1016/j.cell.2024.01.046. Epub 2024 Feb 29.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dr. Shirin Heidari is the lead author of the Sex and Gender Equity in Research (SAGER) guidelines. In this interview with Dr. Isabel Goldman at Cell, she discusses her research, GENDRO, the SAGER guidelines and importance of considering sex- and gender-related variables in research, and her work on sexual and reproductive health in forced displacement.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490177/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490177</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.046>10.1016/j.cell.2024.01.046</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490177</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Shirin Heidari</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Shirin Heidari</dc:title>
<dc:identifier>pmid:38490177</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.046</dc:identifier>
</item>
<item>
<title>The history of sex research: Is "sex" a useful category?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490176/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>The history of sex research demonstrates an ongoing coexistence of multiple, conflicting meanings of sex. This history raises questions for scientists about the deployment of a research variable that lacks precision. Cross-disciplinary collaboration between scientists and science and technology studies (STS) scholars offers a way to find solutions to this problem.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1343-1346. doi: 10.1016/j.cell.2024.02.001.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The history of sex research demonstrates an ongoing coexistence of multiple, conflicting meanings of sex. This history raises questions for scientists about the deployment of a research variable that lacks precision. Cross-disciplinary collaboration between scientists and science and technology studies (STS) scholars offers a way to find solutions to this problem.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490176/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490176</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.001>10.1016/j.cell.2024.02.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490176</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Beans Velocci</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The history of sex research: Is "sex" a useful category?</dc:title>
<dc:identifier>pmid:38490176</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.001</dc:identifier>
</item>
<item>
<title>Closing the scissor-shaped curve: Strategies to promote gender equality in academia</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490175/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Gender inequality in STEM fields remains pervasive and undermines the ability for talented individuals to excel. Despite advances, women still encounter obstacles in pursuing academic careers and reaching leadership positions. This commentary discusses the "scissor-shaped curve" and examines effective strategies to fix it, including data-driven initiatives that we have implemented at our university.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1335-1342. doi: 10.1016/j.cell.2024.01.050.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Gender inequality in STEM fields remains pervasive and undermines the ability for talented individuals to excel. Despite advances, women still encounter obstacles in pursuing academic careers and reaching leadership positions. This commentary discusses the "scissor-shaped curve" and examines effective strategies to fix it, including data-driven initiatives that we have implemented at our university.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490175/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490175</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.01.050>10.1016/j.cell.2024.01.050</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490175</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Johanna A Joyce</dc:creator>
<dc:creator>Slavica Masina</dc:creator>
<dc:creator>Liliane Michalik</dc:creator>
<dc:creator>Caroline Pot</dc:creator>
<dc:creator>Christine Sempoux</dc:creator>
<dc:creator>Francesca Amati</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Closing the scissor-shaped curve: Strategies to promote gender equality in academia</dc:title>
<dc:identifier>pmid:38490175</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.01.050</dc:identifier>
</item>
<item>
<title>Rigorous science demands support of transgender scientists</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490174/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>To build a just, equitable, and diverse academy, scientists and institutions must address systemic barriers that sex and gender minorities face. This Commentary summarizes (1) critical context informing the contemporary oppression of transgender people, (2) how this shapes extant research on sex and gender, and (3) actions to build an inclusive and rigorous academy for all.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1327-1334. doi: 10.1016/j.cell.2024.02.021.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">To build a just, equitable, and diverse academy, scientists and institutions must address systemic barriers that sex and gender minorities face. This Commentary summarizes (1) critical context informing the contemporary oppression of transgender people, (2) how this shapes extant research on sex and gender, and (3) actions to build an inclusive and rigorous academy for all.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490174/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490174</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.021>10.1016/j.cell.2024.02.021</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490174</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Krisha Aghi</dc:creator>
<dc:creator>Brendan M Anderson</dc:creator>
<dc:creator>Bria M Castellano</dc:creator>
<dc:creator>Avery Cunningham</dc:creator>
<dc:creator>Maggie Delano</dc:creator>
<dc:creator>Evyn S Dickinson</dc:creator>
<dc:creator>Lexy von Diezmann</dc:creator>
<dc:creator>Sofia Kirke Forslund-Startceva</dc:creator>
<dc:creator>Dori M Grijseels</dc:creator>
<dc:creator>Sebastian S Groh</dc:creator>
<dc:creator>Eartha Mae Guthman</dc:creator>
<dc:creator>Izzy Jayasinghe</dc:creator>
<dc:creator>Juliet Johnston</dc:creator>
<dc:creator>Sam Long</dc:creator>
<dc:creator>Jess F McLaughlin</dc:creator>
<dc:creator>Maeve McLaughlin</dc:creator>
<dc:creator>Miriam Miyagi</dc:creator>
<dc:creator>Bittu Rajaraman</dc:creator>
<dc:creator>Fátima Sancheznieto</dc:creator>
<dc:creator>Ayden I Scheim</dc:creator>
<dc:creator>Simón E D Sun</dc:creator>
<dc:creator>F Dylan Titmuss</dc:creator>
<dc:creator>Reubs J Walsh</dc:creator>
<dc:creator>Zara Y Weinberg</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Rigorous science demands support of transgender scientists</dc:title>
<dc:identifier>pmid:38490174</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.021</dc:identifier>
</item>
<item>
<title>Sex contextualism in laboratory research: Enhancing rigor and precision in the study of sex-related variables</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490173/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Understanding sex-related variation in health and illness requires rigorous and precise approaches to revealing underlying mechanisms. A first step is to recognize that sex is not in and of itself a causal mechanism; rather, it is a classification system comprising a set of categories, usually assigned according to a range of varying traits. Moving beyond sex as a system of classification to working with concrete and measurable sex-related variables is necessary for precision. Whether and how...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1316-1326. doi: 10.1016/j.cell.2024.02.008.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Understanding sex-related variation in health and illness requires rigorous and precise approaches to revealing underlying mechanisms. A first step is to recognize that sex is not in and of itself a causal mechanism; rather, it is a classification system comprising a set of categories, usually assigned according to a range of varying traits. Moving beyond sex as a system of classification to working with concrete and measurable sex-related variables is necessary for precision. Whether and how these sex-related variables matter-and what patterns of difference they contribute to-will vary in context-specific ways. Second, when researchers incorporate these sex-related variables into research designs, rigorous analytical methods are needed to allow strongly supported conclusions. Third, the interpretation and reporting of sex-related variation require care to ensure that basic and preclinical research advance health equity for all.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490173/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490173</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.008>10.1016/j.cell.2024.02.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490173</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Madeleine Pape</dc:creator>
<dc:creator>Miriam Miyagi</dc:creator>
<dc:creator>Stacey A Ritz</dc:creator>
<dc:creator>Marion Boulicault</dc:creator>
<dc:creator>Sarah S Richardson</dc:creator>
<dc:creator>Donna L Maney</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Sex contextualism in laboratory research: Enhancing rigor and precision in the study of sex-related variables</dc:title>
<dc:identifier>pmid:38490173</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.008</dc:identifier>
</item>
<item>
<title>Exciting science in all formats</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38490172/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Cell expands its formats to include the Short Article and explains why.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Mar 14;187(6):1315. doi: 10.1016/j.cell.2024.02.018.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cell expands its formats to include the Short Article and explains why.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38490172/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38490172</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.02.018>10.1016/j.cell.2024.02.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38490172</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Cell Editorial team</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Exciting science in all formats</dc:title>
<dc:identifier>pmid:38490172</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.02.018</dc:identifier>
</item>
<item>
<title>Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38487879/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Cardiac sEVs, specifically cMSC-sEVs from post-MI hearts, carry multiple protumorigenic factors. Uptake of cMSC-sEVs by cancer cells accelerates tumor growth. Treatment with spironolactone significantly reduces accelerated tumor growth after MI. Our results provide new insight into the mechanism connecting post-MI LVD to cancer and propose a translational option to mitigate this deadly association.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Mar 15. doi: 10.1161/CIRCULATIONAHA.123.066911. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Myocardial infarction (MI) and heart failure are associated with an increased incidence of cancer. However, the mechanism is complex and unclear. Here, we aimed to test our hypothesis that cardiac small extracellular vesicles (sEVs), particularly cardiac mesenchymal stromal cell-derived sEVs (cMSC-sEVs), contribute to the link between post-MI left ventricular dysfunction (LVD) and cancer.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We purified and characterized sEVs from post-MI hearts and cultured cMSCs. Then, we analyzed cMSC-EV cargo and proneoplastic effects on several lines of cancer cells, macrophages, and endothelial cells. Next, we modeled heterotopic and orthotopic lung and breast cancer tumors in mice with post-MI LVD. We transferred cMSC-sEVs to assess sEV biodistribution and its effect on tumor growth. Finally, we tested the effects of sEV depletion and spironolactone treatment on cMSC-EV release and tumor growth.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Post-MI hearts, particularly cMSCs, produced more sEVs with proneoplastic cargo than nonfailing hearts did. Proteomic analysis revealed unique protein profiles and higher quantities of tumor-promoting cytokines, proteins, and microRNAs in cMSC-sEVs from post-MI hearts. The proneoplastic effects of cMSC-sEVs varied with different types of cancer, with lung and colon cancers being more affected than melanoma and breast cancer cell lines. Post-MI cMSC-sEVs also activated resting macrophages into proangiogenic and protumorigenic states in vitro. At 28-day follow-up, mice with post-MI LVD developed larger heterotopic and orthotopic lung tumors than did sham-MI mice. Adoptive transfer of cMSC-sEVs from post-MI hearts accelerated the growth of heterotopic and orthotopic lung tumors, and biodistribution analysis revealed accumulating cMSC-sEVs in tumor cells along with accelerated tumor cell proliferation. sEV depletion reduced the tumor-promoting effects of MI, and adoptive transfer of cMSC-sEVs from post-MI hearts partially restored these effects. Finally, spironolactone treatment reduced the number of cMSC-sEVs and suppressed tumor growth during post-MI LVD.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Cardiac sEVs, specifically cMSC-sEVs from post-MI hearts, carry multiple protumorigenic factors. Uptake of cMSC-sEVs by cancer cells accelerates tumor growth. Treatment with spironolactone significantly reduces accelerated tumor growth after MI. Our results provide new insight into the mechanism connecting post-MI LVD to cancer and propose a translational option to mitigate this deadly association.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38487879/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38487879</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.066911>10.1161/CIRCULATIONAHA.123.066911</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38487879</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Tal Caller</dc:creator>
<dc:creator>Itai Rotem</dc:creator>
<dc:creator>Olga Shaihov-Teper</dc:creator>
<dc:creator>Daria Lendengolts</dc:creator>
<dc:creator>Yeshai Schary</dc:creator>
<dc:creator>Ruty Shai</dc:creator>
<dc:creator>Efrat Glick-Saar</dc:creator>
<dc:creator>Dan Dominissini</dc:creator>
<dc:creator>Menachem Motiei</dc:creator>
<dc:creator>Idan Katzir</dc:creator>
<dc:creator>Rachela Popovtzer</dc:creator>
<dc:creator>Merav Nahmoud</dc:creator>
<dc:creator>Alex Boomgarden</dc:creator>
<dc:creator>Crislyn D'Souza-Schorey</dc:creator>
<dc:creator>Nili Naftali-Shani</dc:creator>
<dc:creator>Jonathan Leor</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth</dc:title>
<dc:identifier>pmid:38487879</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.066911</dc:identifier>
</item>
<item>
<title>Cardioprotection research has left its comfort zone</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38486462/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 15:ehae079. doi: 10.1093/eurheartj/ehae079. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38486462/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38486462</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae079>10.1093/eurheartj/ehae079</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38486462</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Gerd Heusch</dc:creator>
<dc:creator>Petra Kleinbongard</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardioprotection research has left its comfort zone</dc:title>
<dc:identifier>pmid:38486462</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae079</dc:identifier>
</item>
<item>
<title>Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38486376/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Infusion of AZD3366 on top of ticagrelor leads to enhanced cardioprotection compared with ticagrelor alone.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093/eurheartj/ehae107. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: The ecto-nucleoside triphosphate diphosphohydrolases of the CD39 family degrade ATP and ADP into AMP, which is converted into adenosine by the extracellular CD73/ecto-5-nucleotidase. This pathway has been explored in antithrombotic treatments but little in myocardial protection. We have investigated whether the administration of solCD39L3 (AZD3366) confers additional cardioprotection to that of ticagrelor alone in a pre-clinical model of myocardial infarction (MI).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Ticagrelor-treated pigs underwent balloon-induced MI (90 min) and, before reperfusion, received intravenously either vehicle, 1 mg/kg AZD3366 or 3 mg/kg AZD3366. All animals received ticagrelor twice daily for 42 days. A non-treated MI group was run as a control. Serial cardiac magnetic resonance (baseline, Day 3 and Day 42 post-MI), light transmittance aggregometry, bleeding time, and histological and molecular analyses were performed.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Ticagrelor reduced oedema formation and infarct size at Day 3 post-MI vs. controls. A 3 mg/kg AZD3366 provided an additional 45% reduction in oedema and infarct size compared with ticagrelor and a 70% reduction vs. controls (P &lt; .05). At Day 42, infarct size declined in all ticagrelor-administered pigs, particularly in 3 mg/kg AZD3366-treated pigs (P &lt; .05). Left ventricular ejection fraction was diminished at Day 3 in placebo pigs and worsened at Day 42, whereas it remained unaltered in ticagrelor ± AZD3366-administered animals. Pigs administered with 3 mg/kg AZD3366 displayed higher left ventricular ejection fraction upon dobutamine stress at Day 3 and minimal dysfunctional segmental contraction at Day 42 (χ2 P &lt; .05 vs. all). Cardiac and systemic molecular readouts supported these benefits. Interestingly, AZD3366 abolished ADP-induced light transmittance aggregometry without affecting bleeding time.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Infusion of AZD3366 on top of ticagrelor leads to enhanced cardioprotection compared with ticagrelor alone.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38486376/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38486376</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae107>10.1093/eurheartj/ehae107</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38486376</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Gemma Vilahur</dc:creator>
<dc:creator>Monika Radike</dc:creator>
<dc:creator>Pablo Sutelman</dc:creator>
<dc:creator>Soumaya Ben-Aicha</dc:creator>
<dc:creator>Manuel Gutiérrez</dc:creator>
<dc:creator>Laura Casaní</dc:creator>
<dc:creator>Daniel Hovdal</dc:creator>
<dc:creator>Emily L Ongstad</dc:creator>
<dc:creator>Anders Gabrielsen</dc:creator>
<dc:creator>Alberto Hidalgo</dc:creator>
<dc:creator>Ola Fjellström</dc:creator>
<dc:creator>Leif Carlsson</dc:creator>
<dc:creator>Lina Badimon</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction</dc:title>
<dc:identifier>pmid:38486376</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae107</dc:identifier>
</item>
<item>
<title>The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38486368/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 15:ehae123. doi: 10.1093/eurheartj/ehae123. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38486368/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38486368</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae123>10.1093/eurheartj/ehae123</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38486368</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Felicita Andreotti</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:creator>Jurriën M Ten Berg</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment</dc:title>
<dc:identifier>pmid:38486368</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae123</dc:identifier>
</item>
<item>
<title>Anderson-Fabry disease management: role of the cardiologist</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38486361/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240317001020&amp;v=2.18.0.post9+e462414
      <description>Anderson-Fabry disease (AFD) is a lysosomal storage disorder characterized by glycolipid accumulation in cardiac cells, associated with a peculiar form of hypertrophic cardiomyopathy (HCM). Up to 1% of patients with a diagnosis of HCM indeed have AFD. With the availability of targeted therapies for sarcomeric HCM and its genocopies, a timely differential diagnosis is essential. Specifically, the therapeutic landscape for AFD is rapidly evolving and offers increasingly effective,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Mar 15:ehae148. doi: 10.1093/eurheartj/ehae148. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Anderson-Fabry disease (AFD) is a lysosomal storage disorder characterized by glycolipid accumulation in cardiac cells, associated with a peculiar form of hypertrophic cardiomyopathy (HCM). Up to 1% of patients with a diagnosis of HCM indeed have AFD. With the availability of targeted therapies for sarcomeric HCM and its genocopies, a timely differential diagnosis is essential. Specifically, the therapeutic landscape for AFD is rapidly evolving and offers increasingly effective, disease-modifying treatment options. However, diagnosing AFD may be difficult, particularly in the non-classic phenotype with prominent or isolated cardiac involvement and no systemic red flags. For many AFD patients, the clinical journey from initial clinical manifestations to diagnosis and appropriate treatment remains challenging, due to late recognition or utter neglect. Consequently, late initiation of treatment results in an exacerbation of cardiac involvement, representing the main cause of morbidity and mortality, irrespective of gender. Optimal management of AFD patients requires a dedicated multidisciplinary team, in which the cardiologist plays a decisive role, ranging from the differential diagnosis to the prevention of complications and the evaluation of timing for disease-specific therapies. The present review aims to redefine the role of cardiologists across the main decision nodes in contemporary AFD clinical care and drug discovery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38486361/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240317001020&v=2.18.0.post9+e462414">38486361</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae148>10.1093/eurheartj/ehae148</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38486361</guid>
<pubDate>Fri, 15 Mar 2024 06:00:00 -0400</pubDate>
<dc:creator>Maurizio Pieroni</dc:creator>
<dc:creator>Mehdi Namdar</dc:creator>
<dc:creator>Iacopo Olivotto</dc:creator>
<dc:creator>Robert J Desnick</dc:creator>
<dc:date>2024-03-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Anderson-Fabry disease management: role of the cardiologist</dc:title>
<dc:identifier>pmid:38486361</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae148</dc:identifier>
</item>





























</channel>
</rss>